Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

804 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Edoxaban in patients with atrial fibrillation.
Eisen A, Ruff CT. Eisen A, et al. Ther Adv Cardiovasc Dis. 2017 Mar;11(3):81-90. doi: 10.1177/1753944715622130. Epub 2016 Aug 1. Ther Adv Cardiovasc Dis. 2017. PMID: 26680560 Free PMC article. Review.
Edoxaban vs warfarin in patients with nonvalvular atrial fibrillation in the US Food and Drug Administration approval population: An analysis from the Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48 (ENGAGE AF-TIMI 48) trial.
Eisen A, Giugliano RP, Ruff CT, Nordio F, Gogia HS, Awasty VR, Henderson DA, Mercuri MF, Rutman H, Antman EM, Braunwald E. Eisen A, et al. Am Heart J. 2016 Feb;172:144-51. doi: 10.1016/j.ahj.2015.11.004. Epub 2015 Dec 1. Am Heart J. 2016. PMID: 26856226 Clinical Trial.
Updates on Acute Coronary Syndrome: A Review.
Eisen A, Giugliano RP, Braunwald E. Eisen A, et al. JAMA Cardiol. 2016 Sep 1;1(6):718-30. doi: 10.1001/jamacardio.2016.2049. JAMA Cardiol. 2016. PMID: 27438381 Review.
The benefit of adding ezetimibe to statin therapy in patients with prior coronary artery bypass graft surgery and acute coronary syndrome in the IMPROVE-IT trial.
Eisen A, Cannon CP, Blazing MA, Bohula EA, Park JG, Murphy SA, White JA, Giugliano RP, Braunwald E; IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial) Investigators. Eisen A, et al. Eur Heart J. 2016 Dec 21;37(48):3576-3584. doi: 10.1093/eurheartj/ehw377. Epub 2016 Aug 28. Eur Heart J. 2016. PMID: 27569841 Clinical Trial.
804 results